FinTrust Capital Advisors’s Teladoc Health TDOC Stock Holding History

FinTrust Capital Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,935	Closed	-$500K	–	1308
2022 Q1	$500K	Buy	6,935 +132	+2%	+$9.51K	0.11%	165
2021 Q4	$625K	Buy	6,803 +1,410	+26%	+$169K	0.15%	132
2021 Q3	$684K	Buy	5,393 +1,937	+56%	+$282K	0.18%	113
2021 Q2	$575K	Sell	3,456 -803	-19%	-$130K	0.15%	128
2021 Q1	$774K	Buy	4,259 +2,559	+151%	+$594K	0.22%	92
2020 Q4	$340K	Buy	1,700 +1,062	+166%	+$216K	0.11%	163
2020 Q3	$140K	Buy	638 +226	+55%	+$47.9K	0.03%	303
2020 Q2	$79K	Buy	412 +402	+4,020%	+$70.4K	0.03%	384
2020 Q1	$2K	Buy	+10	New	+$1.16K	﹤0.01%	1032

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

FinTrust Capital Advisors's TDOC Position: Q2 2022 in Review

FinTrust Capital Advisors sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 6,935 shares — an estimated $500K sold.

FinTrust Capital Advisors first reported a position in TDOC in Q1 2020 and held it in 9 quarters. The position peaked at $774K in Q1 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

FinTrust Capital Advisors reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
FinTrust Capital Advisors sold 6,935 Teladoc Health shares in Q2 2022, an estimated $500K.
FinTrust Capital Advisors first reported a position in Teladoc Health in Q1 2020 and held it in 9 quarters.
FinTrust Capital Advisors's Teladoc Health position peaked at $774K in Q1 2021.
551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on FinTrust Capital Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.